观点：交感神经系统的慢性激活是全身性高血压的主要促成因素。 - Suppr

Suppr

超能文献

Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.

作者信息

Esler Murray, Lambert Elisabeth, Schlaich Markus

机构信息

Baker IDI Heart and Diabetes Institute, Melbourne, Australia.

出版信息

J Appl Physiol (1985). 2010 Dec;109(6):1996-8; discussion 2016. doi: 10.1152/japplphysiol.00182.2010. Epub 2010 Feb 25.

DOI:10.1152/japplphysiol.00182.2010

PMID:20185633

Abstract

摘要

相似文献

Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.观点：交感神经系统的慢性激活是全身性高血压的主要促成因素。

J Appl Physiol (1985). 2010 Dec;109(6):1996-8; discussion 2016. doi: 10.1152/japplphysiol.00182.2010. Epub 2010 Feb 25.

Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.关于“针锋相对”的评论：系统性高血压的主要促成因素：交感神经系统的慢性激活与肾内肾素 - 血管紧张素系统的激活。交感神经系统的激活是系统性高血压的主要促成因素。

J Appl Physiol (1985). 2010 Dec;109(6):2006.

J Appl Physiol (1985). 2010 Dec;109(6):2007.

Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic nervous system, plasma volume, and hypertension.关于“针锋相对：系统性高血压的主要促成因素：交感神经系统的慢性激活与肾内肾素 - 血管紧张素系统的激活”的评论。交感神经系统、血容量与高血压。

J Appl Physiol (1985). 2010 Dec;109(6):2003. doi: 10.1152/japplphysiol.01160.2010.

J Appl Physiol (1985). 2010 Dec;109(6):2007-8. doi: 10.1152/japplphysiol.01160.2010.

Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Chronic activation of sympathetic nervous system and systemic hypertension--stress shows the way.关于“针锋相对：系统性高血压的主要促成因素：交感神经系统的慢性激活与肾内肾素 - 血管紧张素系统的激活”的评论。交感神经系统的慢性激活与系统性高血压——应激指明方向。

J Appl Physiol (1985). 2010 Dec;109(6):2004-5. doi: 10.1152/japplphysiol.01160.2010.

J Appl Physiol (1985). 2010 Dec;109(6):2006-7. doi: 10.1152/japplphysiol.01160.2010.

J Appl Physiol (1985). 2010 Dec;109(6):2004. doi: 10.1152/japplphysiol.01160.2010.

Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.关于“针锋相对”观点的评论：系统性高血压的主要促成因素：交感神经系统的慢性激活与肾内肾素-血管紧张素系统的激活。激活的肾内肾素-血管紧张素系统与人类高血压相关。

J Appl Physiol (1985). 2010 Dec;109(6):2003. doi: 10.1152/japplphysiol.01160.2010.

Rebuttal from Navar.

J Appl Physiol (1985). 2010 Dec;109(6):2001-2. doi: 10.1152/japplphysiol.00182.2010c.

引用本文的文献

Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease.肾去神经支配对合并及不合并慢性肾脏病的高血压患者糖代谢的影响。

Clin Kidney J. 2025 Jun 18;18(7):sfaf184. doi: 10.1093/ckj/sfaf184. eCollection 2025 Jul.

The KCa3.1 Channel Blocker TRAM-34 and Minocycline Prevent Fructose-Induced Hypertension in Rats.KCa3.1 通道阻断剂 TRAM-34 和米诺环素可预防果糖诱导的大鼠高血压。

Am J Hypertens. 2024 Nov 15;37(12):995-1002. doi: 10.1093/ajh/hpae115.

Causes and consequences of sympathoexcitation across the lifespan: Physiological or pathological?一生中交感神经兴奋的原因及后果：生理的还是病理的？

Exp Physiol. 2023 Oct;108(10):1235-1237. doi: 10.1113/EP091217. Epub 2023 Sep 15.

Central Autonomic Network Regions and Hypertension: Unveiling Sympathetic Activation and Genetic Therapeutic Perspectives.中枢自主神经网络区域与高血压：揭示交感神经激活及基因治疗前景

Biology (Basel). 2023 Aug 21;12(8):1153. doi: 10.3390/biology12081153.

Review Article on Molecular Mechanism of Regulation of Hypertension by Macro-elements (Na, K, Ca and Mg), Micro-elements/Trace Metals (Zn and Cu) and Toxic Elements (Pb and As).宏量元素（钠、钾、钙和镁）、微量元素/痕量金属（锌和铜）及有毒元素（铅和砷）对高血压调节作用的分子机制综述文章

Biol Trace Elem Res. 2024 Apr;202(4):1477-1502. doi: 10.1007/s12011-023-03784-z. Epub 2023 Jul 31.

Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation.REQUIRE 试验中的抗高血压药物依从性：事后探索性评估。

Hypertens Res. 2023 Aug;46(8):2044-2047. doi: 10.1038/s41440-023-01333-8. Epub 2023 Jun 1.

Development and validation of a nomogram model for individualized prediction of hypertension risk in patients with type 2 diabetes mellitus.开发和验证一种列线图模型，用于个体化预测 2 型糖尿病患者的高血压风险。

Sci Rep. 2023 Jan 23;13(1):1298. doi: 10.1038/s41598-023-28059-4.

Clinical Status of Cardiac Rehabilitation Manners and Models.心脏康复方式与模式的临床现状

Cardiol Res Pract. 2022 Jun 27;2022:9554984. doi: 10.1155/2022/9554984. eCollection 2022.

The sympathies of the body: functional organization and neuronal differentiation in the peripheral sympathetic nervous system.身体的共鸣：外周交感神经系统中的功能组织和神经元分化。

Cell Tissue Res. 2021 Dec;386(3):455-475. doi: 10.1007/s00441-021-03548-y. Epub 2021 Nov 10.

A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment.一项针对高血压治疗中肾去神经术患者偏好的日本全国范围的网络调查。

Hypertens Res. 2022 Feb;45(2):232-240. doi: 10.1038/s41440-021-00760-9. Epub 2021 Oct 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验